Skip to content
lifestyle.nextmentors.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
ASIERIS
Asieris Pharmaceuticals Releases 2026 Semi-Annual Report: Core Product Commercialization Delivers, Entering a Harvest Period as the Company Accelerates Its Transition to Biopharma
August 28, 2026
Global Experts Convene at IFCPC 2026: Topical Photodynamic Therapy Reshapes the Individualized Management Paradigm for Cervical Precancerous Lesions
July 17, 2026
Asieris’ CEVIRA® Approved in China as First-in-Class Non-Invasive Therapy for Cervical Precancerous Lesions
March 3, 2026